Drug Delivery and Translational Research

, Volume 2, Issue 2, pp 106–111

Evaluation of a perforated drug delivery system in mice for prolonged and constant release of a hydrophilic drug

Authors

  • Ashish Rastogi
    • US Army Institute of Surgical Research
    • Division of Pharmaceutics, College of PharmacyThe University of Texas at Austin
    • US Army Institute of Surgical Research
    • US Army Institute of Surgical Research
    • Division of Pharmaceutics, College of PharmacyThe University of Texas at Austin
Research Article

DOI: 10.1007/s13346-012-0062-6

Cite this article as:
Rastogi, A., Bowman, P.D. & Stavchansky, S. Drug Deliv. and Transl. Res. (2012) 2: 106. doi:10.1007/s13346-012-0062-6

Abstract

A drug delivery system (DDS) consisting of a perforated microtube (polyimide, inside diameter = 1.8 mm, tube length = 20 mm, hole size = 0.15 mm) was characterized in vitro and in vivo for its usefulness for long-term release of hydrophilic drugs at a constant rate. Sodium fluorescein mixed with stearic acid was used as the model drug. The DDS was packed with sodium fluorescein and stearic acid in ratios of 50:50, 40:60, and 25:75, respectively, and in vitro drug release studies were performed in saline. Linear release rates with R2 > 0.9700 were obtained for all groups. Release rates of 1,077.3 ± 264.6, 342.6 ± 146.4, and 14.4 ± 7.0 μg/day for sodium fluorescein were obtained from the three groups, respectively. After monitoring the in vitro release of fluorescein for 11 days, 7 tubes from the 40:60 group were implanted subcutaneously in each individual mice to study the in vivo release of fluorescein from the tubes by measuring the fluorescein in the urine for 84 days. An initial rapid release during the first 4 days was followed by a near zero order fluorescence from the tubes (R2 = 0.9870). Following completion of the study, the DDSs were retrieved for histology. Morphological analysis indicated no clinical adverse reaction at the site of device implantation specific to the device. The DDS was found to be biocompatible and capable of long-term constant release of a hydrophilic drug such as sodium fluorescein.

Keywords

Drug delivery systemMicroholesStearic acidSodium fluoresceinControlled release

Copyright information

© Controlled Release Society 2012